science glp 1 Science's 2023 Breakthrough of the Year: Weight loss drugs with a real shot at fighting obesity | GLP-1 | Summary
Description
Molecules 27 (19), 6280
10.2337/db08-1193
For patients considering a treatment break, gradual dose reduction over weeksrather than abrupt stoppingmay minimize rebound severity and give the body time to adjust
To our knowledge, at the time of writing there are no trials exploring weight loss in people without T2D
If you have been taking Wegovy for a little while but are still not seeing results, you should speak with your doctor, they may suggest an alternative weight loss treatment
